Diabetes

New research reveals a promising strategy to slow type 1 diabetes progression by targeting inflammation with an existing psoriasis drug.

Research shows comprehensive medication reviews enhance medication adherence in those with type 2 diabetes, highlighting pharmacists' vital role in improving health outcomes.

New research reveals how high blood sugar from type 2 diabetes alters brain function, mimicking early Alzheimer symptoms and impacting memory.

Hospital compounding is gaining renewed attention amid drug shortages, regulatory changes, and labor challenges, prompting pharmacies to leverage advanced technology for safer, more efficient, and compliant medication preparation.

Data show that the system is also the most accurate continuous glucose monitor (CGM).

Pharmacists play a key role in educating patients and prescribers on the selection, use, and management of GLP-1 receptor agonists in diabetes care.

Pharmacists can address micronutrient deficiencies, aiding those with type 2 diabetes as they face a higher risk.

Optimal glycemic control and medication delivery rely upon proper tools and techniques.

Pharmacists can help patients with diabetes save money.

In a debate at the 2025 APhA Annual Meeting, speakers highlighted GLP-1s’ advantages in stroke prevention and weight loss vs SGLT2s’ superiority in heart failure, CV death reduction, and renal protection.

Two pharmacists at the 2025 APhA Annual Meeting debate the role of continuous glucose monitoring (CGM) for non-insulin users, highlighting evolving guidelines, emerging clinical evidence, cost and coverage challenges, and the need for further research to justify widespread adoption.

Health care professionals in the study found it challenging to manage the complexities of disordered eating in patients with type 1 diabetes alongside their other responsibilities.

An expert roundtable discussed what consumers and pharmacists should be aware of as compounded versions of glucagon-like peptide-1 receptor agonists continue to proliferate.

Community pharmacists are uniquely positioned to assist with diabetes management using CGM devices.

Treatment with HTD1801 resulted in significant reductions in the hemoglobin A1c level and improved key cardiometabolic and liver parameters.

The new data emphasize the fundamental differences in management and associated complications with each form of diabetes.

The t:slim X2 insulin pump and Tandem Mobi system both use Control-IQ.

Radon exposure during pregnancy was significantly linked to increased odds of gestational diabetes.

SkinTE could aid Wagner grade 1 diabetic foot ulcers by regenerating and activating the tissues surrounding the wound to heal it completely.

Diabetes management through insulin could play a significant role in preventing antibiotic resistance.

Age, body mass index, and male sex are also associated with the development of diabetes.

Diabetic macular edema (DME) is the leading cause of new blindness in the US.

Overall, there is no long-term increased risk of developing thyroid cancer after initiating treatment with a glucagon-like peptide-1 (GLP-1) receptor agonist, although there is a short-term increase.

The diabetes treatment landscape is rapidly evolving, with new combination therapies and oral GLP-1 medications, positioning pharmacists to have an important role in personalizing care.

Glucose monitoring can help providers and pharmacists optimize medication management for personalized diabetes care.

Jennifer Clements, a clinical professor and the director of pharmacy education at the University of South Carolina, discusses the pharmacists role in diabetes care.

Pharmacy Times interviews Jennifer Clements, a clinical professor and the director of pharmacy education at the University of South Carolina, about glucagon-like peptide-1 receptors for diabetes treatment.

Limited access to healthy food in redlined communities contributes to higher rates of chronic disease and reduced life expectancy.

Age, frequent snoring, hypertension, and poor glycemic control are associated with excessive daytime sleepiness.

However, the effects on patient-reported outcomes were inconclusive when compared with self-monitoring blood glucose or the usual care.